Digestive and Intestinal Remedies Market Research, 2031
The global digestive and intestinal remedies market size was valued at $18,250.0 million in 2021, and is projected to reach $26,243.4 million by 2031, registering a CAGR of 3.6% from 2022 to 2031. The gastrointestinal (GI) symptoms such as heartburn, indigestion dyspepsia, bloating, and constipation are commonly observed in digestive disorders. For instance, diseases such as acid reflux shows symptoms like heartburn and nausea. The disease such as irritable bowel syndrome shows symptoms like abdominal pain, bloating, constipation, gas, and diarrhea. The diagnosis of these conditions vary widely depending on type, cause, and severity of the condition. The treatment of these problems can follow use of antibiotics. However, some of the over the-counter medications used to treat various digestive conditions that include antacids for acid reflux, antidiarrheal for chronic diarrhea, stool softeners, or laxatives for chronic constipation, protectives & adsorbents and saline cathartics. Some prescription medicines can also be used for treatment such as proton pump inhibitors like rabeprazole (Aciphex) and pantoprazole (Protonix) and histamine blockers like cimetidine (Tagamet), ranitidine (Zantac), nizatidine (Axid), famotidine (Pepsid).
Growth of the digestive and intestinal remedies market share is driven by increase in the gastrointestinal disorders cases, changes in the natural food habits and high demand for related over-the-counter products.
In addition, increase in prevalence of digestive diseases like inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness and increase in healthcare expenditure would further supplement the digestive and intestinal remedies market growth. On the other hand, increase in the consumption of supplementary food products and availability of alternative therapies for gastrointestinal diseases are expected to hinder the growth of the market. Conversely, the economic growth in the emerging markets offer digestive and intestinal remedies market opportunity for the growth.
Impact of COVID-19 Pandemic on Digestive & Intestinal Remedies Market
The COVID-19 pandemic affected the digestive and intestinal remedies industry in a fairly positive way, like various other pharmaceutical industries were effected. According to the data of research study named “COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist”, that was published in Digestive Diseases Journal in March 2021, the digestive system may be affected by the SARS-CoV-2 virus, and those with the pre-existing disease are at greatest risk of adverse outcomes. Moreover, according to the research data of American Journal of Physiology named “The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19”, in August 2020, COVID-19 cases with gastrointestinal symptoms are more likely to be complicated by liver injury and acute respiratory distress syndrome (ARDS), if these are not treated in time, coma and circulatory failure may occur.
Overall, the COVID-19 pandemic had a fairly positive impact on the digestive and intestinal remedies industry owing to the increased research and developments activities about the role of gastrointestinal tract in the COVID-19 pandemic. Moreover, increasing prevalence of some gastrointestinal diseases also helped the digestive and intestinal remedies market forecast to boost the growth amidst the pandemic situation.
Digestive & Intestinal Remedies Market Segmentation
The digestive and intestinal remedies market is segmented into Type, Age Group and Distribution Channel. Based on type, the market is classified into digestive medicines and gastrointestinal agents and remedies. Furthermore, the digestive medicines is sub-classified as online and offline. Also, the gastrointestinal agents and remedies is sub-classified as online and offline. Based on age group, the market is classified into pediatric and adult. Based on distribution channel, the market is classified into online and offline. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Type Segment Review
By type, the market is segmented as digestive medicines and gastrointestinal agents and remedies. The gastrointestinal agents and remedies segment is expected to dominate the digestive remedies market during the forecast period, owing to the increase in the use of gastrointestinal agents like antacids protectives and adsorbents. Moreover, the digestive medicines segment is expected to register a CAGR of 4.6% during the forecast period owing to the trends followed like new product launched and various product approvals by the market players.
Age Group Segment Review
By age group, the market is segmented as pediatric and adult. The adult segment is expected to dominate the digestive and intestinal remedies market size during the forecast period, owing to the increase in the prevalence of gastrointestinal disease among the adult population and rise the geriatric population. Moreover, the adult segment is also expected to register a CAGR of 3.7% during the forecast period owing to the rise in the incidences of gastrointestinal problems among the adults for which the over-the-counter drugs can be used.
Distribution Channel Segment Review
By distribution channel, the market is segmented as online and offline. The offline segment is expected to dominate the digestive remedies market during the forecast period, owing to the increase in the number of offline pharmacy stores available for the requirement of the gastrointestinal medicines. Moreover, the online segment is expected to register a CAGR of 4.4% during the forecast period owing to surge in the preferences of the online platforms for the gastrointestinal drugs.
Region Segment Review
Europe accounted for the largest share of revenue in 2021, and is anticipated to maintain its dominance from 2021 to 2031, owing to presence of large patient population, strong presence of key players, ease of drug availability, well developed healthcare infrastructure, higher number of research, development, & innovation activities and higher adoption of advanced therapeutics. However, Asia-Pacific is expected to grow at the highest CAGR of 4.6%, owing to increase in number of target population and rise in awareness related to different gastrointestinal disorders. In addition, increase in healthcare expenditure offers a lucrative opportunity for the digestive and intestinal remedies market share.
Major companies profiled in the report that are considered for the digestive and intestinal remedies market analysis include Abbott Laboratories, Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, GlaxoSmithKline Plc, Jiangzhong Pharmaceutical Co Ltd, Johnson & Johnson, Menarini Group, Merck KGaA, Pfizer Inc., Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group Plc, Sanofi S.A., Taisho Pharmaceutical Holdings Co Ltd, and Takeda Pharmaceutical Company Limited.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive & intestinal remedies market analysis from 2021 to 2031 to identify the prevailing digestive and intestinal remedies market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the digestive and intestinal remedies market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global digestive and intestinal remedies market trends, key players, market segments, application areas, and market growth strategies.
Digestive & Intestinal Remedies Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Age Group |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Menarini Group, Bayer AG, Abbott Laboratories, Sanofi S.A., Bausch Health Companies Inc., Procter & Gamble Company, Takeda Pharmaceutical Company Limited, Merck KGaA, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Glaxosmithkline plc, Johnson & Johnson, Taisho Pharmaceutical Holdings Co Ltd, Prestige Consumer Healthcare Inc., Jiangzhong Pharmaceutical Co Ltd, Reckitt Benckiser Group plc, Pfizer Inc. |
Analyst Review
The utilization of gastrointestinal drugs is expected to witness a significant rise, owing to increase in prevalence of gastrointestinal disorders in both developed and developing economies. Furthermore, the global digestive and intestinal remedies market growth is led by surge in geriatric population, increase in collaboration between pharmaceutical companies for development of novel drugs, and rise in awareness among population.
Europe accounted for the highest market share in 2021, owing to availability of advance gastrointestinal drugs, increase in awareness, and heavy expenditure by the government on healthcare, followed by North America and Asia-Pacific. Asia-Pacific is expected to exhibit fastest market growth, owing to increase in incidences of gastrointestinal disorders. Pharmaceutical companies have focused on expanding their presence in emerging economies, which is anticipated to drive the market growth.
The total market value of Digestive and Intestinal Remedies market is $26,243.4 million in 2031.
The market value of Digestive and Intestinal Remedies market in 2021 is $18,250.0 million.
The forecast period for Digestive and Intestinal Remedies market is 2022 to 2031
The gastrointestinal agents and remedies segment is expected to dominate the market during the forecast period, owing to the increase in the use of gastrointestinal agents like antacids protectives and adsorbents.
Increase in the gastrointestinal disorders cases, changes in the natural food habits and high demand for related over-the-counter products are the key trends of Digestive and Intestinal Remedies Market.
Yes, the Digestive and Intestinal Remedies market companies are profiled in the report
Yes, the Digestive and Intestinal Remedies market report provides PORTER Analysis
The base year is 2021 in Digestive and Intestinal Remedies market
Loading Table Of Content...
